| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Betz Stephen F. is a Chief Scientific Officer at Crinetics Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 5,668 | $24.14 | $136,825.52 | -3.8% | -24.2% | -35.5% | |
| Dec 1, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 5,668 | $27.38 | $155,189.84 | -3.7% | -21.3% | -29.3% | |
| Nov 16, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 7,168 | $27.01 | $193,574.00 | -2.3% | -33.1% | -34.0% | |
| Nov 8, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 16,500 | $28.06 | $463,041.00 | -4.8% | -35.4% | -36.3% | |
| Nov 1, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 5,668 | $24.79 | $140,509.72 | -3.1% | -29.9% | -31.3% | |
| Oct 27, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $24.00 | $71,991.00 | -1.6% | -20.4% | -22.8% | |
| Oct 21, 2021 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,042 | $21.10 | $21,983.60 | -0.6% | -9.8% | -23.2% |